Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Pendleton

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Circulation|April 15, 2009
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsGregory Piazza, Erin J Rosenbaum, William Pendergast, et al.
Journal of the American College of Cardiology|February 5, 2011
Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity studyTheophilus Owan, Erick Avelar, Kimberly Morley, et al.
Journal of the American Medical Informatics Association : JAMIA|October 18, 2014
Value Driven Outcomes (VDO): a pragmatic, modular, and extensible software framework for understanding and improving health care costs and outcomesKensaku Kawamoto, Cary J Martin, Kip Williams, et al.
JAMA|September 20, 2012
Health benefits of gastric bypass surgery after 6 yearsTed D Adams, Lance E Davidson, Sheldon E Litwin, et al.
Obesity (Silver Spring, Md.)|June 6, 2009
Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obeseTed D Adams, Robert C Pendleton, Michael B Strong, et al.
JAMA|October 4, 2017
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.
JAMA|September 4, 2019
Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.
Thrombosis and Haemostasis|December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapyBenjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
The New England Journal of Medicine|November 21, 2013
A pharmacogenetic versus a clinical algorithm for warfarin dosingStephen E Kimmel, Benjamin French, Scott E Kasner, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Circulation|April 15, 2009
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsGregory Piazza, Erin J Rosenbaum, William Pendergast, et al.
Journal of the American College of Cardiology|February 5, 2011
Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity studyTheophilus Owan, Erick Avelar, Kimberly Morley, et al.
Journal of the American Medical Informatics Association : JAMIA|October 18, 2014
Value Driven Outcomes (VDO): a pragmatic, modular, and extensible software framework for understanding and improving health care costs and outcomesKensaku Kawamoto, Cary J Martin, Kip Williams, et al.
JAMA|September 20, 2012
Health benefits of gastric bypass surgery after 6 yearsTed D Adams, Lance E Davidson, Sheldon E Litwin, et al.
Obesity (Silver Spring, Md.)|June 6, 2009
Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obeseTed D Adams, Robert C Pendleton, Michael B Strong, et al.
JAMA|October 4, 2017
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.
JAMA|September 4, 2019
Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.
Thrombosis and Haemostasis|December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapyBenjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
The New England Journal of Medicine|November 21, 2013
A pharmacogenetic versus a clinical algorithm for warfarin dosingStephen E Kimmel, Benjamin French, Scott E Kasner, et al.
Pageof 4